UNSPSC 51312101: Oxomemazine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51312101

Definition

This classification denotes an antimuscarinic agent with the molecular formula C18H22N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 305MB38V1C, chemically known as 10h-phenothiazine-10-propanamine, n,n,beta-trimethyl- but generally known as oxomemazine, which bears US NIH Compound Identifier 5574. European Medicines Agency schedules Oxomemazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09549MIG.

Read the full definition

The term OXOMEMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules oxomemazine in its Anatomical Therapeutic Chemical (ATC) Classification. OXOMEMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxomemazine under HS 29343090 and SITC 51578. As of Q4 2014, OXOMEMAZINE remains the US FDA Preferred Term for this commodity. Oxomemazine bears US NLM identifiers UMLS ID C0768401 and NCI Concept Code C73008.

SMILES: S1C2C(N(CC(CN(C)C)C)C3C1CCCC3)CCCC2.

About UNSPSC 51312101

UNSPSC 51312101 Oxomemazine is a Commodity code that in practice covers pharmaceutical emergency-response products, particularly naloxone and drug deactivation systems, which state and local health agencies procure for community health and opioid-crisis intervention programs. Recent solicitations show state and local governments buying naloxone in bulk quantities paired with safe drug disposal or deactivation systems, supplied through competitive procurement to support quarterly delivery schedules to community health facilities. The issuing bodies pursuing this code include county health departments and special-purpose health authorities managing community health initiatives.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The solicitation, released as a competitive invitation for bid with a response deadline of July 26, 2023, required bidders to include all shipping and delivery costs in their proposals, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace certification. The contract structure provided a two-year initial term with an optional one-year renewal and included a three-month probationary period permitting termination with or without cause. Potential FEMA funding introduced additional federal compliance requirements including adherence to environmental statutes. The source contains only this single recent opportunity and does not support characterization of broader geographic concentration or a wider mix of issuing bodies under this code.

Quick answers

What is UNSPSC 51312101?

UNSPSC 51312101 is Oxomemazine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51312101?

UNSPSC 51312101 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51312101

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code